Claire J Han1, Gee S Yang, Karen Syrjala. 1. Author Affiliations: Department of Public Health, University of Washington, Seattle (Drs Han and Syrjala); College of Nursing, University of Florida, Gainesville (Dr Yang); and Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, Washington (Drs Han and Syrjala).
Abstract
BACKGROUND: With improved survivorship rates for colorectal cancer (CRC), more CRC survivors are living with long-term disease and treatment side effects. Little research exists on CRC symptoms or symptom management guidelines to support these individuals after cancer treatments. OBJECTIVES: The aims of this study were to systematically review symptom experiences, risk factors, and the impact of symptoms and to examine the pooled frequency and severity of symptoms via meta-analyses in CRC survivors after cancer treatments. METHODS: Relevant studies were systematically searched in 7 databases from 2009 to 2019. Meta-analysis was conducted for pooled estimates of symptom frequency and severity. RESULTS: Thirty-five studies met the inclusion criteria. Six studies assessed multiple CRC symptoms, whereas 29 focused on a single symptom, including peripheral neuropathy, psychological distress, fatigue, body image distress, cognitive impairment, and insomnia. The pooled mean frequency was highest for body image distress (78.5%). On a scale of 0 to 100, the pooled mean severity was highest for fatigue (50.1). Gastrointestinal and psychological symptoms, peripheral neuropathy, and insomnia were also major problems in CRC survivors. Multiple factors contributed to adverse symptoms, such as younger age, female gender, and lack of family/social support. Symptoms negatively impacted quality of life, social and sexual functioning, financial status, and caregivers' physical and mental conditions. CONCLUSIONS: Colorectal cancer survivors experienced multiple adverse symptoms related to distinct risk factors. These symptoms negatively impacted patients and caregivers' well-being. IMPLICATIONS FOR PRACTICE: Healthcare providers can use study findings to better assess and monitor patient symptoms after cancer treatments. More research is needed on CRC-specific symptoms and their effective management.
BACKGROUND: With improved survivorship rates for colorectal cancer (CRC), more CRC survivors are living with long-term disease and treatment side effects. Little research exists on CRC symptoms or symptom management guidelines to support these individuals after cancer treatments. OBJECTIVES: The aims of this study were to systematically review symptom experiences, risk factors, and the impact of symptoms and to examine the pooled frequency and severity of symptoms via meta-analyses in CRC survivors after cancer treatments. METHODS: Relevant studies were systematically searched in 7 databases from 2009 to 2019. Meta-analysis was conducted for pooled estimates of symptom frequency and severity. RESULTS: Thirty-five studies met the inclusion criteria. Six studies assessed multiple CRC symptoms, whereas 29 focused on a single symptom, including peripheral neuropathy, psychological distress, fatigue, body image distress, cognitive impairment, and insomnia. The pooled mean frequency was highest for body image distress (78.5%). On a scale of 0 to 100, the pooled mean severity was highest for fatigue (50.1). Gastrointestinal and psychological symptoms, peripheral neuropathy, and insomnia were also major problems in CRC survivors. Multiple factors contributed to adverse symptoms, such as younger age, female gender, and lack of family/social support. Symptoms negatively impacted quality of life, social and sexual functioning, financial status, and caregivers' physical and mental conditions. CONCLUSIONS: Colorectal cancer survivors experienced multiple adverse symptoms related to distinct risk factors. These symptoms negatively impacted patients and caregivers' well-being. IMPLICATIONS FOR PRACTICE: Healthcare providers can use study findings to better assess and monitor patient symptoms after cancer treatments. More research is needed on CRC-specific symptoms and their effective management.
Authors: Susanna B Park; Cindy S Y Lin; Arun V Krishnan; David Goldstein; Michael L Friedlander; Matthew C Kiernan Journal: Oncologist Date: 2011-04-08
Authors: Tracy K Gosselin; Susan Beck; David H Abbott; Steven C Grambow; Dawn Provenzale; Patricia Berry; Katherine L Kahn; Jennifer L Malin Journal: J Pain Symptom Manage Date: 2016-09-30 Impact factor: 3.612
Authors: Melissa S Y Thong; Floortje Mols; Xin S Wang; Valery E P P Lemmens; Tineke J Smilde; Lonneke V van de Poll-Franse Journal: Eur J Cancer Date: 2013-03-01 Impact factor: 9.162
Authors: Manuela Vasconcelos Castro Sales; Claudia K Suemoto; Daniel Apolinario; ValeriaT Serrao; Celi S Andrade; David M Conceição; Edson Amaro; Brian Alvarez Ribeiro de Melo; Rachel P Riechelmann Journal: Clin Colorectal Cancer Date: 2018-09-13 Impact factor: 4.481
Authors: Olga Husson; Floortje Mols; Lonneke V van de Poll-Franse; Melissa S Y Thong Journal: Support Care Cancer Date: 2015-06-28 Impact factor: 3.603
Authors: Alice Avancini; Valeria Pala; Ilaria Trestini; Daniela Tregnago; Luigi Mariani; Sabina Sieri; Vittorio Krogh; Marco Boresta; Michele Milella; Sara Pilotto; Massimo Lanza Journal: Int J Environ Res Public Health Date: 2020-07-24 Impact factor: 3.390
Authors: Benjamin R Fletcher; Sarah Damery; Olalekan Lee Aiyegbusi; Nicola Anderson; Melanie Calvert; Paul Cockwell; James Ferguson; Mike Horton; Muirne C S Paap; Chris Sidey-Gibbons; Anita Slade; Neil Turner; Derek Kyte Journal: PLoS Med Date: 2022-04-06 Impact factor: 11.069
Authors: Alexander J Pennings; Merel L Kimman; Anke H C Gielen; Geerard L Beets; Jarno Melenhorst; Stephanie O Breukink Journal: Colorectal Dis Date: 2021-08-07 Impact factor: 3.917